Findings from this project are promising since people living with HD experience important gastrointestinal dysfuntion. With the BGRF support researchers uncovered a new potential direction of study for these disabling symptoms in HD. By targeting the inflammasome in HD patients, this research identified opportunities to modify the gastrointestinal dysfunction present in this devastating disease.
